• Attorneys
  • Practices & Industries
  • Thought Leadership +
    • Videos
    • Podcasts
    • Publications
      • Chemical Law & Prop 65 Blog
    • Webinars
  • News & Events +
    • News
    • Events/
      Speaking Engagements
  • About
  • Careers
  • Diversity
  • Contact
  • Offices
  • Payment Portal +
    • Pay your invoice
    • Pay your retainer
Buchalter
  • About
  • Careers
  • Diversity
  • Contact
  • Offices
  • Attorneys
  • Practices & Industries
  • Thought Leadership +
    • Publications
      • Chemical Law & Prop 65 Blog
    • Webinars
    • Videos
    • Podcasts
  • News & Events +
    • News
    • Events/
      Speaking Engagements
  • Payment Portal +
    • Pay your invoice
    • Pay your retainer
« View All Events

Jeffrey Garfinkle, Speaker at American Bankruptcy Institute

  • December 3rd, 2020

Jeffrey Garfinkle presents “Anatomy of a Pharmaceutical Bankruptcy Case,” at the American Bankruptcy Institute, Winter Leadership Conference on December 3, 2020.

This panel will present a primer on the U.S. pharmaceutical industry, focusing on the typical capital structures of pharmaceutical/development companies versus in-pipeline companies. The panelists will examine the factors leading to the recent surge in pharmaceutical bankruptcy cases and their outcomes/resolutions, as well as § 363 sales of pharmaceutical companies’ assets and restructurings. Opiate bankruptcy cases such as Purdue and Mallinckrodt will be highlighted, as will ancillary issues that arise in pharmaceutical bankruptcy cases, such as product recalls, regulatory issues (such as with the FDA) and IP licensing issues.

Share

Related Attorneys

  • Jeffrey K. Garfinkle
Buchalter footer logo

Adam Bass, Buchalter President & CEO

  • About
  • Careers
  • News & Events
  • Subscribe
  • CA Privacy Notice
  • PI Opt-Out
  • Denver
  • Los Angeles
  • Napa Valley
  • Orange County
  • Portland
  • Sacramento
  • Salt Lake City
  • San Diego
  • San Francisco
  • Scottsdale
  • Seattle
  • © Copyright 2023 Buchalter, A Professional Corporation
Buchalter Communications

We love sharing our knowledge, but we don't want to inundate you. If you would like to receive communications from Buchalter, please highlight the text boxes below indicating which type of communications you would like to receive, and provide your name and email address. [Street address is only necessary for Points and Authorities.] We appreciate your interest in our work.

  • This field is for validation purposes and should be left unchanged.
  • Sign Up